Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
NASDAQ:APEN
Price:
10 USD
Updated:
May 3, 2024
Apollo Endosurgery Inc
Revenue
|
Apollo Endosurgery Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Revenue
$76.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
4%
|
CAGR 10-Years
28%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Apollo Endosurgery Inc
Revenue Breakdown
Breakdown by Geography
Apollo Endosurgery Inc
Apollo Endosurgery Inc
|
Total Revenue:
76.9m
USD
|
|
United States:
44m
USD
|
|
Ous:
32.9m
USD
|
Breakdown by Segments
Apollo Endosurgery Inc
Apollo Endosurgery Inc
|
Total Revenue:
76.9m
USD
|
|
Ess:
53.9m
USD
|
|
Igb:
22.3m
USD
|
|
Other:
748k
USD
|
See Also
What is Apollo Endosurgery Inc's Revenue?
Revenue
76.9m
USD
76.9m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Revenue amounts to 76.9m USD.
What is Apollo Endosurgery Inc's Revenue growth rate?
Revenue CAGR 10Y
28%
28%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Apollo Endosurgery Inc have been 15% over the past three years , 4% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
